Maxim L Eye Drop is a combination ophthalmic solution containing Loteprednol etabonate 0.5% w/v, a corticosteroid with potent anti-inflammatory properties, and Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic. This formulation is indicated for the treatment of ocular inflammatory conditions accompanied by bacterial infections or where there is a high risk of bacterial contamination. Loteprednol etabonate effectively reduces inflammation, edema, and associated symptoms by inhibiting multiple inflammatory mediators, while Moxifloxacin provides bactericidal activity against a wide range of Gram-positive and Gram-negative pathogens by inhibiting bacterial DNA gyrase and topoisomerase IV. Maxim L Eye Drop is commonly prescribed for postoperative ocular inflammation, allergic conjunctivitis with secondary bacterial infection, and other inflammatory ocular disorders where infection is present or suspected. The combination allows for simultaneous management of inflammation and infection, minimizing the need for multiple medications. It should be used under strict medical supervision, with caution in patients with known hypersensitivity to corticosteroids or fluoroquinolones. Prolonged use may increase the risk of elevated intraocular pressure or secondary infections. Patients should adhere to prescribed dosing schedules and avoid contamination of the dropper tip to ensure safety and efficacy.